Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Change in Acquisitions & Divestments: 2017-2019

Historic Change in Acquisitions & Divestments for Astria Therapeutics (ATXS) over the last 1 years, with Dec 2019 value amounting to $28.4 million.

  • Astria Therapeutics' Change in Acquisitions & Divestments fell 11.65% to $28.4 million in Q4 2019 from the same period last year, while for Dec 2019 it was $151.1 million, marking a year-over-year change of. This contributed to the annual value of $4.1 billion for FY2024, which is 96.80% up from last year.
  • As of Q4 2019, Astria Therapeutics' Change in Acquisitions & Divestments stood at $28.4 million, which was down 41.55% from $48.5 million recorded in Q3 2019.
  • In the past 5 years, Astria Therapeutics' Change in Acquisitions & Divestments ranged from a high of $48.5 million in Q3 2019 and a low of $14.9 million during Q3 2017.
  • For the 3-year period, Astria Therapeutics' Change in Acquisitions & Divestments averaged around $30.4 million, with its median value being $29.3 million (2019).
  • Data for Astria Therapeutics' Change in Acquisitions & Divestments shows a maximum YoY dropped of 11.65% (in 2019) over the last 5 years.
  • Over the past 3 years, Astria Therapeutics' Change in Acquisitions & Divestments (Quarterly) stood at $14.9 million in 2017, then reached $32.1 million in 2018, then decreased by 11.65% to $28.4 million in 2019.
  • Its Change in Acquisitions & Divestments was $28.4 million in Q4 2019, compared to $48.5 million in Q3 2019 and $45.0 million in Q2 2019.